ABSTRACT
Normal Development and in Disease Settings......................................................... 226
9.2 VEGF Isoforms, Family Members, and Receptors ................................................. 227
9.3 Role of VEGF in Tumor Angiogenesis Supports the Notion of Blocking
VEGF as an Antitumor Strategy ............................................................................. 228
9.4 Exploiting Regeneron’s Trap Technology Platform to Create the VEGF Trap ......228
9.5 VEGF Trap Works Impressively in Preclinical Tumor Models...............................230
9.6 VEGF Trap Enters Clinical Trials for Cancer......................................................... 232
9.7 VEGF Trap Works Impressively in Preclinical Models